Inventor · disambiguated record
Ilango Subramanian
Also filed as: SUBRAMANIAN ILANGO
38 granted patents·13 pending applications·13 citations·filing 2020–2024
95Inventor score
Files withSOMERSET THERAPEUTICS LLC51
Top patents by PatentIndex Score
51 records- 0196US11298315B2Triamcinolone and moxifloxacin compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Apr 12, 2022·3 cites·33 claims
- 0294US11969410B2Low pH pilocarpine and brimonidine compound formulations and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Apr 30, 2024·1 cites·17 claims
- 0394US11857539B2Gel ophthalmic formulations of pilocarpine and brimonidine compounds and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jan 2, 2024·1 cites·22 claims
- 0493US12156868B2Formulations of pilocarpine and brimonidine compounds and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Dec 3, 2024·1 cites·12 claims
- 0590US11696910B2Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jul 11, 2023·1 cites·5 claims
- 0690US11478491B2Tobramycin compound-copolymer conjugates and derivative compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Oct 25, 2022·1 cites·8 claims
- 0790US11478492B2Tobramycin compound conjugate formulationsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Oct 25, 2022·1 cites·12 claims
- 0889US11433115B2Glycopeptide antibiotics liquid formulations and methods and uses thereofSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Sep 6, 2022·1 cites·24 claims
- 0989US11298368B2Efficient tobramycin compound conjugate compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Apr 12, 2022·1 cites·9 claims
- 1088US11564931B2Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation propertiesSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jan 31, 2023·1 cites·13 claims
- 1187US11400100B2Effective benzalkonium chloride-free bimatoprost ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2020·Granted Aug 2, 2022·1 cites·29 claims
- 1280US11471403B2Limited particle size triamcinolone and moxifloxacin compositions and associated methods of useSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Oct 18, 2022·0 cites·37 claims
- 1380US11446242B2Suspension component-specific triamcinolone and moxifloxacin compositions and associated methods of useSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Sep 20, 2022·0 cites·33 claims
- 1480US11439591B2Moxifloxacin and triamcinolone compositions and associated methodsSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Sep 13, 2022·0 cites·33 claims
- 1580US2022362274A1Combination products of tobramycin compounds and dexamethasone compoundsSOMERSET THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1678US11344566B2Tobramycin compound conjugates and derivative compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted May 31, 2022·0 cites·5 claims
- 1777US12042502B2Enhanced penetration ophthalmic compositions of bimatoprost and timololSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jul 23, 2024·0 cites·19 claims
- 1877US11883382B2Buffer-free ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 1977US11395831B2Combination products of tobramycin compounds and dexameihasone compoundsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 26, 2022·0 cites·10 claims
- 2077US2024408058A1Compositions for the effective treatment of vitamin c deficiency-related diseases and other conditionsSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2176US11793789B2Treatment of ophthalmological conditions using buffer-free ophthalmological compositions of ketorolac and phenylephrineSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Oct 24, 2023·0 cites·11 claims
- 2276US11590153B2Methods of treating eye disease with tobramycin-related compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Feb 28, 2023·0 cites·22 claims
- 2376US11523987B2Trimcinolone and moxifloxacin methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Dec 13, 2022·0 cites·25 claims
- 2474US12064440B2Ophthalmic gel compositions of bimatoprost and timolol and associated methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Aug 20, 2024·0 cites·17 claims
- 2574US2024398760A1Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 2673US12097178B2Methods of efficiently treating vitamin C deficiency-related diseases and other conditionsSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Sep 24, 2024·0 cites·17 claims
- 2772US12029729B2Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereofSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Jul 9, 2024·0 cites·21 claims
- 2871US12343373B2Glycopeptide antibiotics liquid formulations and methods and uses thereofSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 1, 2025·0 cites·32 claims
- 2971US11786538B2Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation propertiesSOMERSET THERAPEUTICS LLC·Filed 2020·Granted Oct 17, 2023·0 cites·20 claims
- 3071US11382910B2Loteprednol and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 12, 2022·0 cites·31 claims
- 3170US12016855B2Prednisolone and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jun 25, 2024·0 cites·35 claims
- 3270US11484538B2Bromfenac, prednisolone, and moxifloxacin compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Nov 1, 2022·0 cites·31 claims
- 3367US11510930B2Gatifloxacin, prednisolone, and bromfenac compositions and methodsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Nov 29, 2022·0 cites·24 claims
- 3466US2022105100A1Safe brinzolamide and brimonidine compositions with enhanced benzalkonium chloride contentSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 3566US2022105103A1Safe use of brinzolamide and brimonidine compositions with enhanced benzalkonium chloride contentSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 3665US11857538B2Stable pilocarpine formulations with modified buffer characteristics and related methodsSOMERSET THERAPEUTICS LLC·Filed 2023·Granted Jan 2, 2024·0 cites·20 claims
- 3765US2024252475A1Tiotropium combination product compositions and related methodsSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 3864US12128025B2Ready-to-use ascorbic acid compound compositionsSOMERSET THERAPEUTICS LLC·Filed 2022·Granted Oct 29, 2024·0 cites·16 claims
- 3964US2024197676A1Ready-to-use ascorbic acid compound compositionsSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 4064US2024197675A1Ready-to-use ascorbic acid compound compositionsSOMERSET THERAPEUTICS LLC·Filed 2024·Application pending·0 cites
- 4161US2022370396A1Methods for modulating conditions of the eye using novel latanoprost compound ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 4261US2022354784A1Stable latanoprost compound ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 4360US11400068B2Liquid ready-to-use formulation of levothyroxineSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Aug 2, 2022·0 cites·20 claims
- 4459US11850249B2Methods of efficiently reducing intraocular pressureSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Dec 26, 2023·0 cites·14 claims
- 4558US12102632B2Quinolone dispersionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Oct 1, 2024·0 cites·28 claims
- 4657US11517522B2Aprepitant ready-to-use injection emulsion compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Dec 6, 2022·0 cites·15 claims
- 4757US2022016054A1Epinephrine parenteral formulationsSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4856US2021299121A1Cetirizine ophthalmic compositionsSOMERSET THERAPEUTICS LLC·Filed 2021·Application pending·0 cites
- 4953US11382863B2Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroidSOMERSET THERAPEUTICS LLC·Filed 2021·Granted Jul 12, 2022·0 cites·20 claims
- 5051US11433084B2Preparation of microparticulate methylprednisolone acetate suspensionSOMERSET THERAPEUTICS LLC·Filed 2020·Granted Sep 6, 2022·0 cites·14 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →